Product Images Venlafaxine Hydrochloride

This text appears to be a list of drugs and their potential interactions with one another. The interacting drugs listed include ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The effects of these interactions on analytes, such as venlafaxine, are also listed, along with PK Fold Change and 90% CI Recommendation for Cmax and AUC. The recommendations for use vary from avoiding concomitant use to no dose adjustment, depending on the drugs involved and their interactions. Overall, this appears to be a reference guide for healthcare professionals when prescribing medication.*

This appears to be a table of drugs and their interactions, including Cmax and AUC measurements for various analytes. The table provides recommendations for dose adjustment, caution, or avoidance of concomitant use for certain drug interactions. However, without further context, it is difficult to determine the specific purpose or application of this information.*

The text is a table showing PK (pharmacokinetics) recommendations for the use of venlafaxine in patients with different conditions such as hepatic or renal impairment, CYP2D6 polymorphism, age or gender. The table suggests dose adjustments or individualization of dosing based on the analyte and specific conditions. The last line indicates the change relative to the reference value.*

Each capsule contains Venlafaxine Hydrochloride for oral administration. The usual dosage of Venlafaxine Hydrochloride is 37.5mg. The medication comes in Extended-Release Capsules with 30 capsules per bottle. The product is manufactured for Cambir Pharmaceutical and should be dispensed with the prescribing information provided to each patient by the pharmacist. The prescription comes with Rxonly with an identification number of 2100434.*